Also, the development of orally formulated GLP-1 drugs, usually administered via injection, is accelerating availability and patient compliance with enhanced convenience
Liraglutide in apoE / mice reduced body weight as well as suppressed macrophage-driven atherosclerosis
In addition to agonists only target to GLP-1 receptors, agonists with multiple targets now are being developed
Compounded versions of semaglutide existed (and were heavily marketed through telehealth platforms), but the FDA is cracking down on compounders making GLP-1 products now that the drug shortage has ended
Certain lifestyle changes, like high-protein diets, fiber-rich foods, and regular exercise, can naturally boost satiety hormones, though not as powerfully as medical GLP1 therapy